Philippe Bouvet

10PUBLICATIONS
40CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyGene and molecular therapyNonlinear optics and spectroscopy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 23, 2022
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.

Matteo Ponzo, Anais Debesset, Mélissande Cossutta

|Sep 09, 2022
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.

Matteo Ponzo, Anais Debesset, Mélissande Cossutta

|Jan 11, 2022
Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance.

Gabriel Therizols, Zeina Bash-Imam, Baptiste Panthu

|Oct 13, 2021
Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation.

Mounira Chalabi-Dchar, Elisabeth Cruz, Hichem C Mertani

|Jul 02, 2021
Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.

Fabio Raineri, Sandrine Bourgoin-Voillard, Mélissande Cossutta

|Oct 30, 2020
Ribosome Biogenesis Alterations in Colorectal Cancer.

Sophie Nait Slimane, Virginie Marcel, Tanguy Fenouil

Pageof 2

Frequent Collaborators

5 joint publications

Jean-Jacques Diaz

4 joint publications

Mounira Chalabi-Dchar

4 joint publications

Ilaria Cascone

4 joint publications

Hichem C Mertani